Four Seasons Healthcare Expired Insulin Violations CA
NORTH HOLLYWOOD, CA - A state inspection at Four Seasons Healthcare & Wellness Center revealed multiple serious medication safety violations involving insulin administration and storage, placing diabetic residents at risk for potentially life-threatening complications. The April 25, 2025 inspection documented expired insulin being administered to residents, improper injection site rotation, and inadequate medication labeling practices.
Expired Insulin Administered to Diabetic Resident
The most concerning violation involved Resident 90, who received four doses of expired insulin between two dates in 2025. During the inspection, surveyors discovered an opened Lispro Kwikpen insulin pen in Medication Cart Station 2 that had expired but remained in active use. The pen, which had been opened and should have been discarded after 28 days according to manufacturer guidelines, was found with a label indicating it had exceeded its usable timeframe.
Licensed Vocational Nurse 3 acknowledged during the inspection that "administering expired insulin will not be effective in treating residents blood sugar levels and can harm Resident 90 by causing high blood sugar levels leading to coma, hospitalization, and death." The nurse confirmed that the expired pen should have been removed from the medication cart to prevent further administration but had not been discarded as required.
The facility's Director of Nursing confirmed that "several LVNs failed to remove the expired insulin Lispro Kwikpen" and that this resulted in "significant medication errors." The DON acknowledged the serious risks, stating that expired insulin would not effectively control blood sugar levels and could lead to diabetic ketoacidosis (DKA), a potentially fatal condition where acid builds up in the blood due to insufficient insulin.
Repeated Injection Site Violations Affecting Multiple Residents
Inspection records revealed systematic failures in rotating insulin injection sites for at least four residents with diabetes. Resident 52's medical records showed insulin was repeatedly administered to the same body areas, with multiple injections given to the left arm and right lower quadrant of the abdomen without proper rotation between doses.
Similarly, Resident 159, who had severely impaired cognition and required total assistance with daily activities, received multiple insulin injections in the same locations. Records showed the resident received consecutive injections to the left lower quadrant and left arm without the required site rotation. Resident 390's administration records demonstrated the same pattern, with six consecutive insulin injections administered to the left lower quadrant.
The facility's MDS Coordinator confirmed these violations, stating that "the administration sites for insulin should be rotated per standards of practice, manufacturer's guideline, and per physician's order to prevent hardening or lumps in the skin." The coordinator acknowledged that failure to rotate sites constituted medication errors and violated both physician orders and professional standards.
Medical Risks of Improper Insulin Administration
Failure to rotate injection sites causes lipodystrophy, a condition where fatty tissue under the skin either breaks down or builds up abnormally. This creates hardened areas or lumps that significantly impair insulin absorption. When insulin is injected into these damaged areas, the medication cannot be properly absorbed into the bloodstream, leading to unpredictable blood sugar levels.
Lipodystrophy develops gradually when the same injection sites are used repeatedly. The damaged tissue becomes less vascular, meaning fewer blood vessels are available to carry the insulin into circulation. This can result in delayed or incomplete absorption, causing blood sugar to remain dangerously high even after insulin administration. Conversely, if insulin eventually absorbs unpredictably from these sites, it can cause sudden drops in blood sugar (hypoglycemia), which can lead to confusion, seizures, loss of consciousness, and death.
The risks are particularly severe for residents with cognitive impairment who cannot communicate symptoms of blood sugar fluctuations. Resident 159, with severely impaired cognition, and Resident 52, with moderate cognitive impairment and metabolic encephalopathy, were especially vulnerable to these complications as they could not alert staff to symptoms of improper blood sugar control.